Filing Details
- Accession Number:
- 0000899243-16-021419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-02 06:18:13
- Reporting Period:
- 2016-06-01
- Filing Date:
- 2016-06-02
- Accepted Time:
- 2016-06-02 06:18:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662411 | Warren James Huff | 2801 Gateway Drive, Suite 150 Irving TX 75063 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2016-06-01 | 62,657 | $0.00 | 62,657 | No | 4 | C | Direct | |
| Class A Common Stock | Acquisiton | 2016-06-01 | 114,000 | $11.00 | 176,657 | No | 4 | P | Direct | |
| Class A Common Stock | Acquisiton | 2016-06-01 | 3,166 | $0.00 | 3,166 | No | 4 | C | Indirect | By Huff 2010 Descendants' Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct | |
| No | 4 | C | Indirect | By Huff 2010 Descendants' Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class B common stock | Disposition | 2016-06-01 | 62,567 | $0.00 | 62,567 | $0.00 |
| Class A Common Stock | Class B common stock | Disposition | 2016-06-01 | 3,166 | $0.00 | 3,166 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 700,806 | No | 4 | C | Direct | ||
| 35,234 | No | 4 | C | Indirect |
Footnotes
- The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date.
Billionaire Hedge Funds
